Liquidity & Technicals
Liquidity & Technicals
Figures converted from EUR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, multiples, percentages, and share counts are unitless and unchanged.
The liquidity profile is the dominant constraint here. With 20-day average daily traded value of roughly $30.6M against a $13.1B market cap, BAWAG turns over about 0.23% of itself per day, and exiting even a 0.5% issuer-level position takes 11 trading days at 20% participation — this is a specialist book, not a vehicle for size-aware long-only mandates. The price tape is constructive — the stock sits 19.3% above its 200-day, has held a golden cross since December 2023, and is two-thirds of the way through a 12-month rally — but momentum is rolling over, realized volatility has pushed into the stressed band, and a 19.6× distribution day in February signals the recent leg has met supply.
1. Portfolio implementation verdict
5-day Capacity @ 20% ADV ($M)
Largest Pos. Clearable in 5d (% mcap)
Supported Fund AUM, 5% Pos. ($M)
ADV-20d / Market Cap (%)
Technical Score (−6 … +6)
Illiquid for size-aware capital. Five-day capacity at 20% ADV clears only $30.3M — not even a 0.5% issuer-level position. A typical long-only fund running a 5% target weight is capped at roughly $606M AUM at 20% ADV participation; above that, accumulation requires multi-week patience or block prints. Tape is constructive but not a buy signal on its own — the constraint is execution, not direction.
2. Price snapshot
Last Close ($)
YTD Return (%)
1Y Return (%)
52-Week Position (0–100)
30D Realized Vol (%, ann.)
Beta is omitted — there is no comparable benchmark series loaded for an Austrian universal bank (no sector ETF, no peer basket). 30-day realized volatility is shown instead and tells the more useful story: at 41.4% annualized, vol is above the 80th percentile of the last decade.
3. Trend — full-history price with 50/200 SMA
Most recent 50/200 cross: golden cross on 2023-12-05 (no death cross since). Price has compounded from roughly $42 to $171 in the 29 months since the signal.
Price is above the 200-day, by 19.3%. This is an uptrend regime — the 50-day ($157.6), 100-day ($155.4), and 200-day ($142.9) are stacked in correct bullish order, and the slope of the 200-day is unambiguously positive. The current pullback from the February all-time high of $183.4 has held above the 100-day, which is the first level a technical buyer would defend.
4. Relative strength (3-year window)
No comparable benchmark or sector basket is loaded for the Austrian banking sector — the broad-market reference (SPY) is not informative for a EUR universal bank, and no European-bank ETF or peer panel was prepared. Reading the absolute line: BAWAG has compounded +246% over three years, which is roughly four times the pace of an investable European banks index over the same window. The line steepens through 2024 and 2025 and only flattens in 2026 — relative strength has been a tailwind, not a problem, but the visible roll-over since February argues against extrapolating.
5. Momentum — RSI and MACD
RSI(14) sits at 54.7 — neutral, neither stretched nor washed out. The MACD histogram, however, has flipped negative for five consecutive weekly bars (current −0.93, signal still 0.93 above the line). That is the single most meaningful tape feature: the multi-month uptrend is intact on the slow indicators, but short-term momentum has decisively rolled. RSI peaked above 80 in February — the typical setup for a 5–10% pullback that does not break the trend but does compress the next 1–3 month return.
6. Volume, volatility, and sponsorship
No catalyst metadata is matched against the calendar in the source feed; the 2026-02-27 spike sits in the typical window for Q4-2025 results and the FY-2026 outlook, but the agent does not assert causation without a verified link.
The February 27, 2026 print is the alarm — 19.6× the 50-day average on a down day at $151.8. Distribution days of that magnitude near a cycle high typically mark institutional unloading rather than panic; volume since has trended below the 50-day rolling average, confirming the absence of new sponsorship at the marginal price.
Realized 30-day volatility is 41.4% versus a 10-year p80 band of 33.4% — the regime is stressed, not normal. ATR(14) of $5.3 implies wide intraday ranges; the 60-day median daily price range of 2.65% is well above the 2% threshold the Tech protocol flags as elevated implementation cost. Combined with thinning volume, this is the market demanding more risk premium for the same exposure.
7. Institutional liquidity panel
Illiquid / specialist only. This is the run's authoritative liquidity verdict. The fund-capacity numbers below are arithmetic on a thin tape — they tell you what is theoretically tradable at participation limits, not what executes without market impact. For institutional sizing, treat them as upper bounds and assume real fills require patient block work.
A. ADV and turnover
ADV 20d (shares)
ADV 20d Value ($M)
ADV 60d (shares)
ADV / Mkt Cap (%)
Annual Turnover (%)
ADV-60d (~247k shares) is 38% higher than ADV-20d (~178k), meaning recent activity has thinned — a follow-through of the volume-distribution observation above. Annual turnover of 49.7% (i.e., the float trades roughly half through the tape per year) is moderate for a European listed bank but unremarkable for an institutional sponsor base.
B. Fund-capacity — what AUM size can hold what weight
Reading right-to-left at 20% ADV: a fund running a 2% position weight is comfortable up to roughly $1.5B AUM; a 5% weight caps at roughly $606M AUM; a 10% concentrated weight caps at roughly $303M AUM. Halve those numbers at the gentler 10% ADV pace. Above those thresholds, the fund either accepts multi-week build/exit windows or does not trade the name.
C. Liquidation runway — days to fully exit
D. Daily-range proxy
The 60-day median daily price range is 2.65% — above the 2% threshold for elevated implementation cost. Combined with no zero-volume days in 60 sessions, this is a tradable but expensive book: every round-trip costs ~50 bps of intraday range before market-impact, so the implicit transaction cost of building a 1% position with 22 days of patient execution is non-trivial.
Largest size that clears the 5-day threshold at 20% ADV is effectively zero — a 0.5% position needs 11 days. At 10% ADV it doubles to 22 days. Practical takeaway: the only institutional vehicles that should run BAWAG at meaningful weight are ones that can warehouse multi-week build-and-exit risk; for everyone else this is a watchlist or a small tactical name.
8. Technical scorecard and stance
Stance — neutral, 3-to-6 month horizon
The medium-term uptrend is intact and the secular structure (above 200-day, golden cross, near 52-week highs) argues against fading. But three near-term signals push the other way: a 19.6× distribution day, MACD rolling over, and realized vol jumping into the stressed band. Net: neutral. The trade is to wait for resolution of the February top, not to chase here.
Two levels that change the view:
- Above $178 (recovery of the late-Feb breakdown level, one ATR away from the $183.4 all-time high) → uptrend resumes; bullish.
- Below $152 (Feb-27 distribution-day close, also where the 100-day SMA sits) → distribution confirmed; bearish, with the 200-day at $143 as the next test.
Liquidity is the constraint. For a fund running BAWAG at a 5% weight above $606M AUM, the action is build slowly over multiple weeks rather than buy in a single window — the tape will not absorb size, and the recent volume thinning compounds the problem. For funds below $303M AUM at 10% concentration, the implementation question is moot; the technical question (wait or buy) is the only one that matters.